The SIOG COVID-19 working group recommendations on the rollout of COVID-19 vaccines among older adults with cancer

Anna Rachelle Mislang, Enrique Soto-Perez-De-Celis, Chiara Russo, Giuseppe Colloca, Grant R. Williams, Shane O'Hanlon, Lisa Cooper, Anita O'Donovan, Riccardo A. Audisio, Kwok-Leung Cheung, Regina Gironés Sarrió, Reinhard Stauder, Michael Jaklitsch, Clarito Cairo, Luiz Antonio Gil, Schroder Sattar, Kumud Kantilal, Kah Poh Loh, Stuart M. Lichtman, Etienne BrainHans Wildiers, Ravindran Kanesvaran, Nicolò Matteo Luca Battisti

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
3 Downloads (Pure)


The COVID-19 pandemic continues to negatively impact our society. Older adults are at increased risk of morbidity and mortality. People who are frail, living in residential care facility, and/or with comorbidities, including cancer are disproportionately disadvantaged. To reduce the risk of infection among older adults with cancer, several anticancer therapies have been prioritized, delayed, de-escalated, or omitted based on clinical need ([1]). However, public health interventions remain critical to mitigate transmission and minimize adverse outcomes. Of these, mass immunization is perhaps a more effective preventive health measure and potentially a key exit strategy from this crisis.
Original languageEnglish
Pages (from-to)848-850
Number of pages3
JournalJournal of Geriatric Oncology
Issue number5
Early online date5 Mar 2021
Publication statusPublished - 1 Jun 2021


  • COVID-19
  • Cancer
  • Older patients
  • SIOG
  • Vaccine

Cite this